technetium 99m has been researched along with c.i. 42510 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akay, CL; Babiera, GV; DeSnyder, SM; Krishnamurthy, S; Kuerer, HM; Le-Petross, C; Lucci, A; Mittendorf, EA; Ueno, NT; Whitman, GJ; Woodward, WA; Yang, W | 1 |
| Abitbol, J; Gotlieb, WH; How, J; Kessous, R; Kogan, L; Lau, S; Puzhakkal, S; Salvador, S; Yasmeen, A | 1 |
2 trial(s) available for technetium 99m and c.i. 42510
| Article | Year |
|---|---|
Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; False Negative Reactions; Feasibility Studies; Female; Humans; Inflammatory Breast Neoplasms; Lymphatic Metastasis; Mastectomy, Simple; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Period; Prospective Studies; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Technetium; Treatment Outcome; Ultrasonography | 2018 |
Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment.
Topics: Aged; Coloring Agents; Endometrial Neoplasms; Female; Humans; Indocyanine Green; Lymphatic Metastasis; Middle Aged; Prospective Studies; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Technetium | 2019 |